- Home
- /
- Company Overview
About Lambda Therapeutic Research
Lambda Therapeutic Research is a leading Global Clinical Research Organization (CRO), headquartered in Ahmedabad, India, with operations across Mehsana (India), Las Vegas (USA), Toronto (Canada), London (UK), Barcelona (Spain), and Warsaw (Poland).
Our mission is simple yet powerful: to deliver end-to-end clinical research solutions for innovators, biotech companies, and generic pharmaceutical manufacturers worldwide. With decades of experience and a proven track record, Lambda is redefining excellence in clinical research through innovation, compliance, and collaboration.
Lambda consistently sets new standards in the Clinical Research sector, achieving milestones through both organic growth and strategic acquisitions. In 2019, we strategically expanded our North American presence by acquiring Novum Pharmaceutical Research Services, a distinguished CRO with 50 years of legacy. This strategic move, following the integration of Biovail’s R&D facilities in Canada in 2010, marked Lambda’s second significant acquisition in North America.
Operating under the unified brand of Novum Pharmaceutical Research Services in North America, Lambda Therapeutic Research continues to reinforce its position as a leading global Clinical Research Organization (CRO). This strategic integration enables us to deliver consistent, high-quality clinical research solutions across multiple geographies.
At Lambda, excellence isn’t just a goal, it’s our standard. We’ve invested heavily in a team of 1,200+ highly skilled professionals and advanced digital platforms to ensure precision and efficiency in every project. By prioritizing secure IT infrastructure, automation, and data integrity, we ensure timely project delivery while meeting stringent global regulatory standards. Lambda’s reputation for compliance and quality is backed by an exceptional regulatory track record. Over the past five years, we have successfully completed 60+ international inspections and audits by leading authorities, including USFDA, EMA, MHRA, EU member states, and other global regulatory bodies. This achievement showcases Lambda’s unwavering commitment to global clinical research excellence, consistently meeting and exceeding international regulatory standards.
At Lambda Therapeutic Research, we take pride in being recognized for our expertise and unwavering commitment to quality. Over the years, we’ve earned several prestigious awards that reflect our leadership in clinical research. We were honored as the “Best Indian CRO” by Frost & Sullivan (USA) and acknowledged as a “Great Indian Workplace” by UBS Transformance. Recently, we received the “Regulatory Excellence Award” at the CPhI Awards 2023 and were named “Industry Partner of the Year” at the Global Generics & Biosimilar Awards 2023. We are proud to be among the finalists for the Industry Partner of the Year Award at the Global Generics & Biosimilar Awards 2024. Industry Outlook has ranked Lambda among the Top 10 CROs in 2022 and the Top 10 Contract Research Organizations in 2023. These accolades reflect our strong focus on regulatory compliance, industry leadership, and strategic collaborations with biotech, pharmaceutical, and clinical research innovators worldwide.
Why Lambda?
We combine the full-service capabilities and global reach to support biotech and pharmaceutical companies with tailored clinical development and resource solutions.
A Truly Global CRO with Multi-continental Presence
Comprehensive Clinical Research Services
Best Credit rating in CRO Industry
Strong Leadership with 20+ years of Experience
Globally Recognized for Research Excellence
Let's Unveil New Therapies Together
Connect with our experts to leverage our proven track record of clinical research excellence.